U.S. government got $400 million in vaccine royalties from Moderna, company says
(Worthy News) – Pharmaceutical company Moderna indicated this week that it had sent the U.S. government a “catch-up” payment of $400 million in connection with a patent dispute.
The company concluded an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) in December of last year, establishing “a nonexclusive patent license agreement” allowing the company to use disputed technologies in its production of the COVID-19 vaccine, the Epoch Times reported.
In addition to the $400 million payment to NIAID, Moderna will “pay low single-digit royalties on future net sales of our COVID-19 vaccines,” according to Moderna CFO Jamey Mock. [ Source: Just the News (Read More…) ]
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌